Skip to content

A randomized, double-blind, parallel controlled trial for Zhizhu prescription in the treatment of slow transit constipation

A randomized, double-blind, parallel controlled trial for Zhizhu prescription in the treatment of slow transit constipation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003380
Enrollment
Unknown
Registered
2020-06-07
Start date
2020-06-03
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

slow transit constipation

Interventions

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patient meets the diagnostic criteria of Rome IV and the diagnosis of deficiency syndrome of traditional Chinese medicine; (2) Aged 18 to 80 years old (women of childbearing age need to take contraceptive measures during the study period); (3) The patient can cooperate with the treatment, and the doctor can obtain the patient's detailed history and fill in the score scale of the history; (4) the interval between the end time of the last other treatment and treatment of this study is more than 1 week; (5) patients agree not to use any food or drugs that affect gastrointestinal peristalsis during treatment; (6) patients agree to accept the treatment process and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) women during pregnancy and lactation; (2) those who are allergic to the drugs in this study; (3) Patients with outlet obstruction constipation and irritable bowel syndrome; (4) Those who have taken other defecation promoting drugs within 1 week before treatment or during treatment; (5) Patients with serious primary diseases such as cardiovascular,urinary, hematopoietic, endocrine system and malignant tumors, and patients with a history of alcohol and drug abuse and psychosis; (6) Patients with intestinal stenosis caused by organic lesions (such as Crohn's disease, colonic polyps and intestinal tuberculosis) or those with a history of abdominal surgery; (7) Fail to take medicine according to the regulation, cause curative effect cannot judge, or because the life environment often changes and other factors easily cause the loss of visitors.

Design outcomes

Primary

MeasureTime frame
Bristol stool form scale (BSFS);Therapeutic effect score of TCM syndromes;the Patient Assessment of Constipation Quality of Life (PAC-QOL);Cleveland Clinic Constipation Score (CCS);

Countries

China

Contacts

Public ContactLiu Penglin

The Affiliated Hospital of Qingdao University

kong-22277@163.com+86 18661809006

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026